Chen Schor - 24 Jan 2026 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
24 Jan 2026
Net transactions value
-$14,812
Form type
4
Filing time
27 Jan 2026, 16:45:07 UTC
Previous filing
29 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schor Chen President & CEO, Director C/O ADICET BIO, INC., 131 DARTMOUTH STREET, FLOOR 3, BOSTON /s/ Nick Harvey, Attorney-in-Fact 27 Jan 2026 0001340875

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Tax liability $14,812 -1,755 -20% $8.44 6,820 24 Jan 2026 Direct F1, F2
holding ACET Common Stock 2,716 24 Jan 2026 See Footnote F2, F3
holding ACET Common Stock 3,339 24 Jan 2026 See Footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
F2 Reflects a 1-for-16 reverse stock split effected by the Issuer on December 30, 2025.
F3 Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.
F4 Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.